Sepsis, Endocarditis & Antimicrobial Principles
Key Takeaways
The 2026 Surviving Sepsis Campaign distinguishes probable or definite sepsis from possible infection without shock when setting antibiotic timing.
Fluid resuscitation requires ongoing reassessment; TBI changes the usual balanced-crystalloid preference toward 0.9% saline.
Infective endocarditis may produce embolic infarction, infected aneurysm, abscess, or intracranial hemorrhage.
Antimicrobial selection depends on source, host, local susceptibility, CNS penetration, organ clearance, and source control.
Identify Infection Without Missing Its Mimics
Sepsis is life-threatening organ dysfunction associated with a dysregulated response to infection. In the neuro-ICU, altered consciousness, fever, tachycardia, leukocytosis, or hypotension may also arise from seizures, central fever, drug withdrawal, pulmonary embolism, endocrine crises, or sympathetic hyperactivity. A positive culture can represent contamination or colonization. Use the clinical syndrome and likely source, while beginning emergency stabilization promptly when sepsis is probable.
Assess airway, oxygenation, perfusion, lactate trends, urine output, skin findings, devices, and potential infection sources. Obtain appropriate cultures before antibiotics when this does not cause an important treatment delay. A normal lactate does not exclude sepsis, and an elevated lactate can reflect adrenergic stimulation or impaired clearance in addition to hypoperfusion. Repeated assessment is more useful than interpreting a single number in isolation.
Current Timing and Circulatory Guidance
The 2026 Surviving Sepsis Campaign recommends immediate antimicrobial therapy, ideally within one hour of recognition, for probable or definite sepsis, including shock. For possible sepsis without shock, it supports rapid, time-limited investigation and treatment within three hours if concern persists. A low likelihood of infection without shock permits close monitoring while further evaluation proceeds. This framework avoids treating every unexplained fever as proven sepsis while preserving urgency when serious infection is likely.
For sepsis-induced hypoperfusion or shock, the guideline suggests at least 30 mL/kg of IV crystalloid within three hours, with explicit consideration of individual context and frequent reassessment. Do not mechanically administer additional fluid despite pulmonary edema or evidence of poor fluid tolerance. Unstable shock may warrant concurrent vasopressors and fluid. Norepinephrine is a principal first-line pressor; temporary peripheral administration through an appropriate monitored site can avoid delay while central access is arranged.
A usual initial MAP target around 65 mm Hg may need modification when intracranial pressure or another neurologic condition requires a higher perfusion pressure. The guideline generally favors balanced crystalloids but specifically suggests 0.9% saline in sepsis with TBI. Avoid supplemental albumin in TBI. These distinctions are important because a general ICU recommendation cannot be transferred automatically to every neurologically injured patient.
Choose Antibiotics for the Actual Infection
| Factor | Practical implication |
|---|---|
| Source | Pneumonia, urinary infection, abdominal infection, line infection, and meningitis need different coverage and source control |
| Exposure and local resistance | Recent hospitalization, antimicrobial exposure, devices, and local susceptibility guide resistant-organism coverage |
| Host | Neutropenia, transplant drugs, HIV, and cellular therapies change likely pathogens |
| Site penetration | Suspected CNS infection requires an appropriate CNS-active regimen |
| Clearance and toxicity | Adjust maintenance dosing for renal or hepatic dysfunction and renal replacement; monitor selected drug levels |
A loading dose and a maintenance dose answer different pharmacokinetic questions. Do not automatically reduce an urgently needed loading dose simply because renal function is impaired. Subsequent dosing must account for clearance, volume of distribution, dialysis, and organism susceptibility. Prolonged beta-lactam infusion can improve time-dependent exposure in selected settings, but compatibility and delivery must be reliable.
Reassess daily, narrow therapy when microbiology and the clinical course permit, and discontinue treatment when an alternative diagnosis is established. Procalcitonin is an adjunct in selected decisions rather than a substitute for clinical assessment. Antibiotics alone may fail when infected hardware, an obstructed urinary tract, an undrained abscess, or another source remains uncontrolled.
Endocarditis and Neurologic Complications
Infective endocarditis should be considered when bacteremia, embolic infarcts in multiple territories, new valve findings, persistent fever, or a relevant device or exposure is present. Obtain blood cultures and echocardiographic evaluation. TEE may be required when TTE is nondiagnostic and suspicion remains, especially with prosthetic valves or devices. Lack of a loud murmur does not exclude infection.
Neurologic events include septic embolic infarction, hemorrhagic transformation, infected intracranial aneurysm, meningitis, and abscess. A thunderclap headache or new hemorrhage may require vascular imaging. IV thrombolysis for stroke associated with infective endocarditis is hazardous because hemorrhagic complications can occur; selected mechanical interventions require specialist assessment. Valve-surgery timing after a neurologic complication balances uncontrolled infection or cardiac failure against hemorrhage and operative risks.
Encephalopathy in the Immunocompromised Host
Immunosuppressed patients may have infection without robust fever or CSF inflammation. Consider the immune defect, time since transplant or treatment, prophylaxis, exposures, and imaging pattern. Opportunistic infections and treatment toxicity can coexist. Broad coverage may be needed initially, but each additional drug creates interaction and toxicity risks, including calcineurin-inhibitor interactions, beta-lactam neurotoxicity, and marrow suppression. Consult infectious diseases and pharmacy rather than treating all post-transplant encephalopathy with one generic regimen.
Sources checked October 17, 2026: 2026 adult Surviving Sepsis Campaign and IDSA healthcare-associated CNS infection guideline.
A patient has probable sepsis with shock and rising vasopressor needs. Which strategy is appropriate?
Delay all antibiotics until final cultures
Treat fever alone and defer shock evaluation
Give unlimited crystalloid without reassessment
Begin prompt antimicrobial treatment, resuscitation, cultures when feasible, and source assessment
Multiple-territory cerebral infarcts accompany persistent bacteremia and a new valve abnormality. What diagnosis should be investigated?
Infective endocarditis with cerebral embolization
Benign central fever only
Isolated SIADH
Propofol infusion syndrome established by definition
Sections you finish are checked off in the contents.